Translating Evidence Into Clinical Practice for Pediatric Patients With Hereditary Angioedema
Translating Evidence Into Clinical Practice for Pediatric Patients With Hereditary Angioedema is organized by Prime Education, LLC.
Release Date: March 17, 2023
Expiration Date: March 16, 2024
Description:
An expanding pharmacologic landscape has generated opportunities for patients with hereditary angioedema (HAE) to live attack-free. However, it has also created challenges for healthcare professionals in selecting the optimal therapy for each individual.
This clinical case challenge will guide you through a real-world scenario as you select among treatment options for a pediatric patient and apply strategies to utilize shared decision-making with a parent/caregiver.
Don't miss this opportunity to hone your skills and compare your results against your peers.
Challenge #1 of 2.
This activity is delivered in partnership with the Allergy & Asthma Network.
Agenda:
• Differentiating HAE Therapies Based on Indication and Mechanism of Action
• Translating Safety and Efficacy Data for Novel HAE Treatments Into Clinical Practice
Learning Objectives:
• Differentiate current and emerging treatments based on the latest clinical safety and efficacy data, mechanism of action, indication, and route and frequency of administration
• Develop individualized management plans that integrate patient- and disease-specific factors into personalized treatment decisions
• Apply patient education and shared decision-making to long-term prophylactic treatment discussions for staying attack-free